Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)Kate Franklyn, Eric F. Morand, Mandana Nikpour et al.|Annals of the Rheumatic Diseases|2015Cited by 728
Short- and potential long-term adverse health outcomes of COVID-19: a rapid reviewMiriam T Y Leung, Ian Chi Kei Wong, Adrienne Y L Chan et al.|Emerging Microbes & Infections|2020Cited by 240
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation studyVera Golder, Eric F. Morand, Rangi Kandane‐Rathnayake et al.|The Lancet Rheumatology|2019Cited by 161
Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series studyCeline Sze Ling Chui, Ian Chi Kei Wong, Min Fan et al.|EClinicalMedicine|2022Cited by 55
Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Hospitalized Patients With COVID-19Eric Yuk Fai Wan, Esther W. Chan, Vincent Ka Chun Yan et al.|Annals of Internal Medicine|2023Cited by 54